BRIEF-Tiziana Announces Last Patient Successfully Dosed In Its Phase 2 Inform-MS Trial

Tiziana Life Sciences plc

Tiziana Life Sciences plc

TLSA

0.00

June 25 (Reuters) - Tiziana Life Sciences Ltd TLSA.O:

  • TIZIANA ANNOUNCES LAST PATIENT SUCCESSFULLY DOSED IN ITS PHASE 2 INFORM-MS TRIAL

  • TIZIANA LIFE SCIENCES - TOPLINE DATA FROM INFORM-MS TRIAL EXPECTED LATE Q3 OR EARLY Q4 2026

Source text: ID:nGNX5xKx79

Further company coverage: TLSA.O


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.